SRC and gastric cancer: Tatematsu et al. [42,43] used PCS, GOS, and sialidase GOS with immunohistochemical stains for pepsinogen I and II to distinguish 127 SRC-GC as gastric phenotype, intestinal phenotype, or mixed gastrointestinal phenotype, with the gastric phenotype resulting in the most prevalent subtype.